Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 12 Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 5 Prostatic Neoplasms 4 Solid Tumor 3 Neoplasm Metastasis 3 Melanoma 3 Recurrence 2 Pancreatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Gastrointestinal Stromal Tumors 2 Colonic Neoplasms 2 Choledocholithiasis 2 Carcinoma 2 Advanced Solid Tumor 2 cMET-dysregulated Advanced Solid Tumors 1 Terminal Cancer 1 Synovitis, Pigmented Villonodular 1 Stomach Neoplasms 1 Solid Tumours 1 Solid Tumour 1 Solid Tumors 1 Skin Neoplasms 1 Respiratory Aspiration 1 Respiration Disorders 1 Rectal Neoplasms 1 Rare Diseases 1 Prostate Cancer Patients 1

Interventions

Midazolam 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Terminal Cancer × Midazolam × Clear all

NCT02009306 2018-05-09

Nasal Fentanyl and Buccal Midazolam for Dying Patients

Gloucestershire Hospitals NHS Foundation Trust

Phase 4 Completed

Terminal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡